Basilea's Ceftobiprole On TARGET, Needs Positive Second Study For US

 
• By John Davis
  
Staphylococcus aureus
Staphylococcus aureus, a target for ceftobiprole • Source: Shutterstock

More from Clinical Trials

More from R&D